Pharmacists want scrapping of ex post facto reporting after substitute drug dispensing

Published: 2003-03-04 06:58:00

Updated: 2003-03-04 06:58:00

The current regulation requiring a pharmacy to make ex post facto reporting after substitute drug dispensing should be waivered for more expanded function of pharmacists and stable dispensing right, according to proposals released by the general meeting of 16 regional chapters of the Korea Pharma...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK